Building a scalable compliance framework for European expansion

Background

When we were engaged by a rapidly growing pharmaceutical company, they were expanding across multiple European markets while managing increasing regulatory complexity. Their operations spanned six jurisdictions, each with its own local requirements alongside broader UK and EU pharmaceutical compliance frameworks.

The organisation recognised the need for a more structured and audit-ready compliance programme. However, this needed to be implemented without disrupting commercial activity or slowing expansion. The challenge was to introduce consistency and oversight across markets while maintaining flexibility at a local level.

The LS Law Approach

We approached the engagement by designing a compliance framework that could operate across jurisdictions while remaining practical for day-to-day use. Our focus was on creating a structure that aligned with regulatory expectations but also supported commercial execution.

We deployed a senior former in-house Ethics and Compliance leader with experience of building multi-country programmes, supported by local country experts. This ensured that the framework reflected both central requirements and local regulatory nuances.

We established a centralised compliance architecture, providing a consistent foundation across all territories. This included structured governance for interactions with healthcare professionals and a clear approach to transparency reporting.

We also implemented a more efficient process for the review of promotional materials through Veeva, enabling greater consistency without introducing delays. Alongside this, we introduced a formal audit cycle, including audit, corrective actions, and re-audit monitoring, to ensure ongoing compliance.

To support oversight at leadership level, we developed executive dashboards and introduced regulatory horizon scanning to enable forward planning and early identification of potential risks.

The Outcome

The organisation established a compliance framework that provided both control and scalability across multiple jurisdictions.

There was improved visibility of compliance activity, with clearer reporting and oversight at both local and central levels. Regulatory risk was reduced through more consistent processes and structured monitoring.

Importantly, the framework supported continued expansion. The organisation was able to enter new markets with a defined compliance model already in place, rather than building processes on an ad hoc basis.

The result was a compliance infrastructure that aligned with growth, enabling the business to scale while maintaining regulatory standards.